KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Restructuring Costs (2018 - 2025)

Historic Restructuring Costs for Arbutus Biopharma (ABUS) over the last 6 years, with Q3 2025 value amounting to $98000.0.

  • Arbutus Biopharma's Restructuring Costs fell 9729.66% to $98000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year increase of 25216.55%. This contributed to the annual value of $3.7 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Arbutus Biopharma's Restructuring Costs is $98000.0, which was down 9729.66% from $200000.0 recorded in Q2 2025.
  • Arbutus Biopharma's Restructuring Costs' 5-year high stood at $12.4 million during Q1 2025, with a 5-year trough of $95000.0 in Q4 2024.